CLINICAL USE


Laxative

DOSE IN NORMAL RENAL FUNCTION

1–3 sachets daily in divided doses in 125 mL of waterMaintenance: 1–2 sachets daily

PHARMACOKINETICS

  • Molecular weight &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp :3350
  • %Protein binding &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp :Not absorbed
  • %Excreted unchanged in urine &nbsp &nbsp : Not absorbed
  • Volume of distribution (L/kg) &nbsp &nbsp &nbsp :Not absorbed
  • half-life – normal/ESRD (hrs)&nbsp &nbsp &nbsp :Not absorbed

    DOSE IN RENAL IMPAIRMENT

    GFR (mL/MIN)

  • 20 to 50 &nbsp &nbsp : Dose as in normal renal function
  • 10 to 20 &nbsp &nbsp : Dose as in normal renal function
  • <10 &nbsp &nbsp &nbsp &nbsp &nbsp : Dose as in normal renal function

    DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES

  • CAPD &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp:Not dialysed. Dose as in normal renal function

  • HD &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp :Not dialysed. Dose as in normal renal function
  • HDF/high flux &nbsp :Not dialysed. Dose as in normal renal function
  • CAV/VVHD &nbsp &nbsp &nbsp:Not dialysed. Dose as in normal renal function

    IMPORTANT DRUG INTERACTIONS

    Potentially hazardous interactions with other drugs
  • None known

    ADMINISTRATION

    Reconstition

    Route

    Oral

    Rate of Administration

    Comments

    OTHER INFORMATION

    Movicol contains polyethylene glycol, sodium chloride, sodium bicarbonate and potassium chlorideElectrolyte content of a sachet when made up with 125 mL water is:Sodium 65 mmol/L —Chloride 53 mmol/L —Potassium 5.4 mmol/L —Bicarbonate 17 mmol/L —Sachets are formulated to ensure that there is virtually no net gain or loss of sodium, potassium or waterMovicol (active ingredient is the osmotic laxative polyethylene glycol).